Literature DB >> 15100253

Breaking immune tolerance to the prion protein using prion protein peptides plus oligodeoxynucleotide-CpG in mice.

Martine Bruley Rosset1, Clara Ballerini, Sylvie Gregoire, Pat Metharom, Claude Carnaud, Pierre Aucouturier.   

Abstract

The absence of a detectable immune response during transmissible spongiform encephalopathies is likely due to the fact that the essential component of infectious agents, the prion protein (PrP), is a self Ag expressed on the surface of many cells of the host. To overcome self-tolerance to PrP, we used 30-mer PrP peptides previously shown to be immunogenic in Prnp(-/-) mice, together with CFA or CpG-oligodeoxynucleotides (CpG) in IFA. Generation of anti-PrP T and B cell responses was analyzed in the spleen, lymph nodes, and serum of immunized C57BL/6 wild-type mice. Immunization with PrP peptides emulsified in CFA did not trigger an immune response to PrP. When CpG were used, vaccination with peptides P143-172 and P158-187 generated IFN-gamma-secreting splenic T cells, and only P158-187 significantly stimulated IL-4-secreting T cells. Both peptides induced few Ab-producing B cells, and low and variable serum Ab titers. In contrast, immunization with peptide P98-127 did not induce significant levels of T cell responses but elicited specific peptide Abs. T cell epitope mapping, performed using 15-mer peptides covering PrP segment 142-182, revealed that an immunogenic motif lies between positions 156 and 172. These results demonstrate that T and B cell repertoires against PrP can be stimulated in C57BL/6 when adjuvant of the innate immunity such as CpG, but not CFA, is added to PrP peptides, and that the pattern of immune responses varies according to the epitope.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100253     DOI: 10.4049/jimmunol.172.9.5168

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  In vitro neutralization of prions with PrP(Sc)-specific antibodies.

Authors:  Ryan Taschuk; Jacques Van der Merwe; Kristen Marciniuk; Andrew Potter; Neil Cashman; Philip Griebel; Scott Napper
Journal:  Prion       Date:  2015       Impact factor: 3.931

2.  Generation of antibodies against bovine recombinant prion protein in various strains of mice.

Authors:  Olga Andrievskaia; Heather McRae; Cathy Elmgren; Hongsheng Huang; Aru Balachandran; Klaus Nielsen
Journal:  Clin Vaccine Immunol       Date:  2006-01

3.  Immunity to a self-derived, channel-forming peptide in the respiratory tract.

Authors:  Frederik W van Ginkel; Takeo Iwamoto; Bruce D Schultz; John M Tomich
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

4.  Cell-based immunotherapy of prion diseases by adoptive transfer of antigen-loaded dendritic cells or antigen-primed CD(4+) T lymphocytes.

Authors:  Claude Carnaud; Véronique Bachy
Journal:  Prion       Date:  2010-04-04       Impact factor: 3.931

5.  Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP.

Authors:  Daphne Nikles; Patricia Bach; Klaus Boller; Christoph A Merten; Fabio Montrasio; Frank L Heppner; Adriano Aguzzi; Klaus Cichutek; Ulrich Kalinke; Christian J Buchholz
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge.

Authors:  Natalia Fernandez-Borges; Alejandro Brun; J Lindsay Whitton; Beatriz Parra; Fayna Diaz-San Segundo; Francisco J Salguero; Juan M Torres; Fernando Rodriguez
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 7.  Amyloid-beta immunisation for Alzheimer's disease.

Authors:  Thomas Wisniewski; Uwe Konietzko
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

8.  Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection.

Authors:  Magdalini Polymenidou; Frank L Heppner; Erica C Pellicioli; Eduard Urich; Gino Miele; Nathalie Braun; Franziska Wopfner; Hermann M Schätzl; Burkhard Becher; Adriano Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-03       Impact factor: 11.205

9.  A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen.

Authors:  William M Gwinn; Brandi T Johnson; Shaun M Kirwan; Ashley E Sobel; Soman N Abraham; Michael D Gunn; Herman F Staats
Journal:  Vaccine       Date:  2013-01-23       Impact factor: 3.641

10.  Detection and control of prion diseases in food animals.

Authors:  Peter Hedlin; Ryan Taschuk; Andrew Potter; Philip Griebel; Scott Napper
Journal:  ISRN Vet Sci       Date:  2012-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.